SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010510
Filing Date
2017-05-11
Accepted
2017-05-11 15:37:52
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q albo-10q_20170331.htm 10-Q 1015073
2 EX-10.1 albo-ex101_158.htm EX-10.1 28812
3 EX-31.1 albo-ex311_159.htm EX-31.1 8313
4 EX-31.2 albo-ex312_160.htm EX-31.2 8191
5 EX-32.1 albo-ex321_161.htm EX-32.1 8647
  Complete submission text file 0001564590-17-010510.txt   4210817

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT albo-20170331.xml EX-101.INS 784086
7 XBRL TAXONOMY EXTENSION SCHEMA albo-20170331.xsd EX-101.SCH 37660
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE albo-20170331_cal.xml EX-101.CAL 30715
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE albo-20170331_def.xml EX-101.DEF 142167
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20170331_lab.xml EX-101.LAB 315320
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20170331_pre.xml EX-101.PRE 247375
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 17834045
SIC: 2834 Pharmaceutical Preparations